
Business Of Biotech
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect.
Podcasting since 2020 • 258 episodes
Business Of Biotech
Latest Episodes
The Discovery Of Microbes And Implications For Public Health Today, With Science Writer Thomas Levenson
On this week's episode, Thomas Levenson, MIT professor and author of So Very Small: How Humans Discovered The Microcosmos, Defeated Germs — And May Still Lose The War Against Infectious Disease talks about what...
•
Episode 257
•
1:06:27

Psychedelics For Mental Health Disorders With atai's Srinivas Rao, M.D., Ph.D.
On this week's episode, Dr. Srinivas Rao, co-founder and CEO at atai Life Sciences, explains how his engineering background led him to the development of psychedelic compounds for treating depression, anxiety, and other mental health disorders....
•
Episode 256
•
55:50

Biotech Angel Investing With Yaniv Sneor
On this week's episode, Yaniv Sneor, founder of the Mid Atlantic Bio Angels and CEO at Native State Therapeutics, explains how life science angel investors evaluate biotech startups, and offers tips for young drug developers in search of fundin...
•
Episode 255
•
56:27

Leading A tRNA Startup With Alltrna's Michelle Werner
On this week's episode, Michelle Werner, CEO at Alltrna, talks transfer RNA (tRNA) therapy with host Ben Comer and guest co-host Anna Rose Welch, editorial and community director at Advancing RNA. Wer...
•
Episode 254
•
59:23

Executing A Product Pivot With Vir Bio's Mark Eisner, MD
On this week's episode of the Business of Biotech, Dr. Mark Eisner, EVP and Chief Medical Officer at Vir Bio, talks about the company's post-COVID pivot into infectious diseases (Hepatitis Delta and Hepatitis B) and oncology (solid tumors), how...
•
Episode 253
•
39:45

Contributors
Podcasts we love
Check out these other fine podcasts recommended by us, not an algorithm.
